Insider Selling: Chemed Co. (NYSE:CHE) CEO Sells 1,000 Shares of Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the transaction, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This trade represents a 0.97 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Chemed Stock Performance

Chemed stock opened at $619.47 on Friday. The stock has a market capitalization of $9.07 billion, a price-to-earnings ratio of 31.30, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $639.61. The stock’s 50 day moving average price is $579.29 and its two-hundred day moving average price is $567.98.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Monday, February 24th. Chemed’s payout ratio is 10.05%.

Institutional Investors Weigh In On Chemed

Several hedge funds and other institutional investors have recently bought and sold shares of CHE. Raymond James Financial Inc. acquired a new stake in shares of Chemed in the 4th quarter valued at about $42,023,000. HighTower Advisors LLC boosted its holdings in Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after acquiring an additional 1,634 shares in the last quarter. XTX Topco Ltd boosted its holdings in Chemed by 111.5% in the third quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock worth $1,709,000 after acquiring an additional 1,499 shares in the last quarter. Geode Capital Management LLC grew its stake in Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after acquiring an additional 15,791 shares during the period. Finally, Signal Advisors Wealth LLC increased its holdings in shares of Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after acquiring an additional 1,886 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CHE has been the topic of several recent analyst reports. Royal Bank of Canada boosted their target price on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a report on Friday, March 14th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.